Clinical Features,Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study)

MLA

Ventre, Marta Bruno, et al. “Clinical Features,Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study).” Oncologist, vol. 19, no. 3, Mar. 2014, pp. 291–98. EBSCOhost, https://doi.org/10.1634/theoncologist.2013-0249.

APA

Ventre, M. B., Ferreri, A. J. M., Gospodarowicz, M., Govi, S., Messina, C., Porter, D., Radford, J., Heo, D. S., Park, Y., Martinelli, G., Taylor, E., Lucraft, H., Hong, A., ScarfÒ, L., Zucca, E., & Christie, D. (2014). Clinical Features,Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study). Oncologist, 19(3), 291–298. https://doi.org/10.1634/theoncologist.2013-0249

Chicago

Ventre, Marta Bruno, Andr´Es J. M. Ferreri, Mary Gospodarowicz, Silvia Govi, Carlo Messina, David Porter, John Radford, et al. 2014. “Clinical Features,Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study).” Oncologist 19 (3): 291–98. doi:10.1634/theoncologist.2013-0249.